Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma (Q37283401)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 2008
edit
Language Label Description Also known as
English
Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma
scientific article published on October 2008

    Statements

    Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma (English)
    1 October 2008
    2361-2366

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit